ストックスクリーナーアプリを入手
8.12
5.47%
-0.47
アフターアワーズ：
8.11
-0.010
-0.12%
Eupraxia Pharmaceuticals Inc (EPRX) 最新ニュース
Eupraxia Pharmaceuticals Inc. (TSE:EPRX) surges 15%; retail investors who own 41% shares profited along with institutions - simplywall.st
Eupraxia Trial Data Shows Lasting Tissue Healing In Patients With Inflamed Esophagus - Sahm
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Earnings Impact & AI Forecasted Entry/Exit Points - ulpravda.ru
What insider trading reveals about Eupraxia Pharmaceuticals Inc. stockWeekly Investment Summary & Smart Allocation Stock Tips - ulpravda.ru
Is Eupraxia Pharmaceuticals Inc. stock a buy on dips2025 Price Action Summary & Stepwise Trade Signal Guides - ulpravda.ru
Will Eupraxia Pharmaceuticals Inc. stock continue dividend increases2025 Big Picture & Consistent Growth Stock Picks - ulpravda.ru
How Eupraxia Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - ulpravda.ru
(EPRX.WT.A) Investment Analysis and Advice - Stock Traders Daily
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - Investing News Network
Eupraxia Pharmaceuticals Announces Positive Tissue Health Data From Its Ongoing RESOLVE Trial - Nasdaq
Eupraxia Posts Strong Mid-Stage Data for Once-Yearly EoE Therapy EP-104GI - TipRanks
Eupraxia Pharmaceuticals reports positive tissue health data from its ongoing resolve trial - MarketScreener
Eupraxia Pharmaceuticals Brief: Reporting "Positive" Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - MarketScreener
Once-yearly EoE treatment shows near-healed esophagus tissue, no serious harms - Stock Titan
(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Up 0.3% – Here’s What Happened - Defense World
(EPRX.WT.A) Advanced Equity Analysis - Stock Traders Daily
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Stock Trading Blueprint - Stock Traders Daily
(EPRX) Comprehensive Trading Strategy Report (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Daily Stock Insights - Stock Traders Daily
Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Short Interest Up 30.1% in December - MarketBeat
Trading (EPRX) With Integrated Risk Controls (EPRX:CA) - Stock Traders Daily
How the (EPRX.WT.A) price action is used to our Advantage - Stock Traders Daily
(EPRX) Equity Market Report (EPRX:CA) - Stock Traders Daily
562,500 Non-Voting Class B Shares of Eupraxia Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - MarketScreener
Can Eupraxia Pharmaceuticals Inc. stock sustain institutional interest2025 Major Catalysts & Low Drawdown Trading Techniques - Улправда
Will Eupraxia Pharmaceuticals Inc. stock reach Wall Street targetsEntry Point & Community Verified Swing Trade Signals - Улправда
(EPRX) Advanced Trading Insights (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Why Eupraxia Pharmaceuticals Inc. stock is a must watch in 2025Quarterly Trade Report & Long-Term Safe Return Strategies - Улправда
Moving Averages: Why Eupraxia Pharmaceuticals Inc. stock is a must watch in 2025July 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Can Eupraxia Pharmaceuticals Inc. stock beat analyst upgradesMarket Movement Recap & Free Weekly Chart Analysis and Trade Guides - Улправда
Stock Report: Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidanceJuly 2025 Price Swings & Long-Term Safe Return Strategies - Улправда
Why Eupraxia Pharmaceuticals Inc. stock could see breakout soonDay Trade & Risk Controlled Stock Pick Alerts - Улправда
Aug Decliners: Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Historical Comparison & Daily Chart Pattern Signals - Улправда
Aug Final Week: How Eupraxia Pharmaceuticals Inc. stock valuations compare to rivalsTrend Reversal & High Accuracy Investment Entry Signals - Улправда
How geopolitical risks impact Eupraxia Pharmaceuticals Inc. (X43) stockWeekly Trade Review & Risk Controlled Swing Alerts - Улправда
Market Review: Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolutionTrade Entry Summary & Growth Oriented Trade Recommendations - Улправда
(EPRX.WT.A) Stock Evaluation Report - Stock Traders Daily
Why Eupraxia Pharmaceuticals Inc. stock remains a top recommendationProduct Launch & Intraday High Probability Alerts - DonanımHaber
Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidance2025 Risk Factors & Daily Market Momentum Tracking - Улправда
Bearish Setup: Why Eupraxia Pharmaceuticals Inc. stock could see breakout soon2025 Institutional Moves & Low Risk Entry Point Tips - Улправда
(EPRX.WT.A) Strategic Equity Report - Stock Traders Daily
How to Take Advantage of moves in (EPRX) (EPRX:CA) - news.stocktradersdaily.com
FY2025 Earnings Estimate for EPRX Issued By Lifesci Capital - MarketBeat
(EPRX.WT.A) Risk-Controlled Trading Report - news.stocktradersdaily.com
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Shares Down 0.3% – Here’s Why - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Raised to Strong-Buy at Lifesci Capital - Defense World
New Highs: How Eupraxia Pharmaceuticals Inc stock reacts to global recession fears2025 Historical Comparison & Fast Moving Trade Plans - moha.gov.vn
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to "Strong-Buy" at Lifesci Capital - MarketBeat
0.90%
大文字化:
|
ボリューム (24 時間):